Wildcard: Is Clover Health a Disruptor or Distractor?
Clover Health (NASDAQ: CLOV) has been one of the most controversial Medicare insurance providers since being brought public by Social Capital and Hedosophia. In this Wildcard episode, Motley Fool contributor Jason Hall and analyst Emily Flippen discuss Clover’s business, its unique value proposition, and then debate if the controversial short-seller report should have investors running for the door.
Check out more of our content here:
StockUp, The Motley Fool's weekly email newsletter
Reach us by Email @ IndustryFocus@fool.com
Listen to Wildcard: Is Clover Health a Disruptor or Distractor?
Recent Episodes
Listen
Listen
Listen
Listen
or jump to a specific page
CG: Getting Blunt About Cannabis Stocks
Motley Fool contributor and resident cannabis expert Keith Speights joins host Emily Flippen as they celebrate 4/20 by talking about how investors should (and shouldn’t!) get invested in marijuana, as well as some of their favorite ideas for all types of listeners.
Stocks: Square (SQ), PayPal (PYPL), Scotts MiracleGro (SMG), Innovative Industrial Properties (IIPR), AYR Wellness (AYRWF), Trulieve Cannabis (TCNNF)
Check out more of our content here:
Podcasts
Youtube
Twitter
Reach us by Email @ IndustryFocus@fool.com
Apr 20, 2021 • 35:58 • Industry Focus
Listen